Arecor Therapeutics plc (LON:AREC – Get Free Report) shares hit a new 52-week low on Thursday . The company traded as low as GBX 48 ($0.62) and last traded at GBX 49.01 ($0.64), with a volume of 10588 shares trading hands. The stock had previously closed at GBX 50.50 ($0.65).
Arecor Therapeutics Stock Down 2.9 %
The company has a debt-to-equity ratio of 5.51, a current ratio of 1.37 and a quick ratio of 6.24. The company has a market capitalization of £18.51 million, a PE ratio of -1.73 and a beta of -0.18. The company has a 50-day moving average of GBX 56.82 and a two-hundred day moving average of GBX 67.82.
About Arecor Therapeutics
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
Featured Stories
- Five stocks we like better than Arecor Therapeutics
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Undervalued Stocks You Can Buy at a Discount Now
- What is the Dow Jones Industrial Average (DJIA)?
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- Canadian Penny Stocks: Can They Make You Rich?
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
